Imaging Tumor Response to Therapy
Measurement of solid tumor response to treatment relies mainly on imaging. WHO tumor response criteria and, more recently, RECIST (response evaluation criteria in solid tumors) have provided means to objectively measure tumor response in clinical trials with imaging. These guidelines have been rapid...
Συγγραφή απο Οργανισμό/Αρχή: | |
---|---|
Άλλοι συγγραφείς: | , |
Μορφή: | Ηλεκτρονική πηγή Ηλ. βιβλίο |
Γλώσσα: | English |
Έκδοση: |
Milano :
Springer Milan : Imprint: Springer,
2012.
|
Θέματα: | |
Διαθέσιμο Online: | Full Text via HEAL-Link |
Πίνακας περιεχομένων:
- Part I Methodological Bases
- 1 Surrogate Endpoints of Clinical Benefit
- 2 Response to Treatment: the Role of Imaging
- Part II RECIST and Beyond: Assessing the Response to Treatment in Metastatic Disease
- 3 Gastrointestinal Stromal Tumors
- 4 Renal Cancer
- 5 Liver Metastases in Colon Cancer
- Part III RECIST and Beyond: Assessing the Response to Treatment in Locally Advanced Disease
- 6 Neoadjuvant Therapy in Breast Cancer
- 7 Lung Cancer
- 8 Pancreatic Cancer
- 9 Hepatocellular Carcinoma.